Proteome Sciences Dividend

Dividend criteria checks 0/6

Proteome Sciences does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	0.6%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-UK£0.0083
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PRM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PRM's dividend payments have been increasing.

Dividend Yield vs Market

Proteome Sciences Dividend Yield vs Market

How does PRM dividend yield compare to the market?
Segment	Dividend Yield
Company (PRM)	n/a
Market Bottom 25% (GB)	2.1%
Market Top 25% (GB)	5.7%
Industry Average (Life Sciences)	0.6%
Analyst forecast in 3 Years (PRM)	n/a

Notable Dividend: Unable to evaluate PRM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PRM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PRM's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PRM has not reported any payouts.

Proteome Sciences Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

New major risk - Share price stability

Full year 2023 earnings released: UK£0.008 loss per share (vs UK£0.004 profit in FY 2022)

Proteome Sciences plc, Annual General Meeting, May 16, 2024

New minor risk - Financial data availability

New major risk - Share price stability

Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Proteome Sciences plc Announces the Launch of Sysquant® SCP, the Commercial Service for Single Cell Proteomics Using the Power of its TMTpro™ Isobaric Labelling Reagents

First half 2023 earnings released: UK£0.002 loss per share (vs UK£0 in 1H 2022)

Now 43% undervalued

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Full year 2022 earnings released: EPS: UK£0.004 (vs UK£0 in FY 2021)

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Less than half of directors are independent

Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Proteome Sciences plc Appoints Abdel Ghani Omari as the Company's New Chief Financial Officer

First half 2022 earnings released

Proteome Sciences plc Completes Milestone Towards Launch of single Cell Proteomics Services

Less than half of directors are independent

Full year 2021 earnings released: EPS: UK£0 (vs UK£0.001 in FY 2020)

Proteome Sciences plc, Annual General Meeting, May 16, 2022

Now 25% undervalued after recent price drop

Proteome Sciences plc to Report Fiscal Year 2021 Results on Mar 31, 2022

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Proteome Sciences plc Provides Earnings Guidance for the Financial Year Ended 31 December 2021

Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.002 loss in 1H 2020)

Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Full year 2020 earnings released: EPS UK£0.001 (vs UK£0.001 in FY 2019)

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies